Sign Up Today and Learn More About Kernal Biologics Stock
Invest in or calculate the value of your shares in Kernal Biologics or other pre-IPO companies through EquityZen's platform.
Kernal Biologics Stock (KEBI)
Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.
About Kernal Biologics Stock
Founded
2016
Headquarters
Cambridge, MA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Kernal Biologics Press Mentions
Stay in the know about the latest news on Kernal Biologics
Amgen joins Kernal Bio’s $25M financing as the startup brings mRNA 2.0 to cancer
bit • Aug 15, 2022
The Vast Promise of mRNA Technology
on • Aug 15, 2022
You’ve met Moderna, BioNTech and CureVac. Now meet Kernal Bio, the startup working on mRNA 2.0
bit • Aug 15, 2022
New toilet, a VR camera and science experiments are heading to the space station
cnn • Aug 15, 2022
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
prnewswire • Jul 08, 2022
Kernal Biologics Management
Leadership team at Kernal Biologics
Co-Founder, CEO
Yusuf Erkul
Investor
Helen Liang
Join now and verify your accreditation status to gain access to:
- Kernal Biologics current valuation
- Kernal Biologics stock price
- Available deals in Kernal Biologics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Kernal Biologics stock?
Accredited investors can buy pre-IPO stock in companies like Kernal Biologics through EquityZen funds. These investments are made available by existing Kernal Biologics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Kernal Biologics stock?
Shareholders can sell their Kernal Biologics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
